Connect with us

Featured

Yield Growth Reports Revenue of $800,714 in First Quarter Financial Results and Provides Operational Update

Avatar

Published

on

default_cannabis_industry_cannamaps

VANCOUVER, British Columbia, April 26, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt: YG3) on a consolidated basis (the “Company”, “us”, “we”) provides an operational update and releases financial and operational results for the first quarter ended February 28, 2019.  These filings are available for review on the Company’s SEDAR profile at www.sedar.com.
We have made significant achievements in building our brand assets and we are well positioned for future growth with a comprehensive line up of our hemp and cannabis infused products. Currently we own 100% of the following brand assets:Urban Juve™This is our flagship brand, a unisex skin and personal care line with hemp root extract as its main ingredient.  We currently have 11 products on the market, being sold in the US and Canada through e-commerce and through retail stores in Canada.  Over 70 retail stores in Canada have agreed to carry the line, and we are now signing retailers in the United States (the “US”).  We are launching our products in Asia this spring, starting with e-commerce set up on Chinese messaging and mobile payment application WeChat.  Urban Juve has been well received by the press since its launch in Q1, with positive write ups in Elle Canada Magazine, Zoomer and The Growth Op. Our Anti-aging serum made it into this year’s pre-Oscar event bags.In addition to acquiring wellness formulas for body care, facial care and therapeutic products, we have also developed products through our in-house research and development team. To date we have filed 11 provisional patent applications in the US and one Patent Co-operation Treaty patent application which can be used as a basis for obtaining patent protection in over 170 countries. Our extraction technology is designed to preserve potentially therapeutic compounds in the cannabis root and enhance penetration into the skin. Urban Juve is a bold brand rooted in the organic synthesis of ancient knowledge and modern techniques to create exceptional beauty and wellness solutions. Ayurvedic knowledge delineates three general categories or skin types, which Urban Juve has translated as Vitalize, Balance and Align, each with its own dedicated range of skin and body care formulations.Urban Juve is in planning to launch over 30 additional products over the next year and these include: 3 Lip glosses, 3 body exfoliants, 3 facial masks, cream facial cleanser, Facial Cleansing Pads, micellar water, eye cream, 2 facial oils, deodorant, foot cream, a full men’s line and essential oil blends.Wright & Well™Wright & Well is our cannabis wellness brand that will be launching in Oregon, US in Q2 or Q3 2019. The products are intended to help relieve pain and anxiety.  The initial nine products include analgesic topical gel with tetrahydrocannabinol (“THC”) and Cannabidiol (“CBD”), THC and CBD oils, pain balm with THC and CBD, massage oil with THC and CBD, and three types of capsules containing THC and Ayurvedic herbal formulations, blended with ingredients that have historically been used to treat arthritis and chronic pain.Wright & Well branded products will be launching in the legal cannabis market in Oregon and will serve the growing number of wellness-minded people seeking new ways to take control of their health. Sophisticated, familiar and intelligent, the new brand aims to demystify the world of cannabis and make it more accessible for a wider audience.We intend to license our brand and provide our formulas and packaging, as well as point of sales materials, to licensed cannabis manufacturers, distributors and retailers in various jurisdictions. We currently have discussions with cannabis license holders in the State of Washington, Nevada, California, New York, as well as Canada and other countries.  Our plan is to roll out our brand internationally, one territory at a time.Mad Wallaby™We are developing a line of products for cannabidiol infusion with the primary target market being the US. With the adoption of the Farm Bill into law in late 2018, topical products containing CBD are now federally legal in the US, subject to state law and compliance with the FDA. We have engaged New York marketing agency The Design Spot to create a brand identity and initial packaging design for this CBD product line.  The design spot is a design and branding company located in the heart of New York City with a team of award-winning designers and with a portfolio that includes L’Oreal, Revlon and Dove.   Mad Wallaby has been set up as a California corporation and our intention is to use it to distribute our brands in the US.UJ BeveragesWe currently have a line of 8 fruit beverages in development and we have 10 tea formulas in our catalogue. The fruit beverage formulations were developed in India and are based on Ayurvedic medicine using botanicals, fruit extracts and natural botanical extracts, including hemp extracts.  The main beverages are good on their own and can also be infused with cannabinoids such as CBD and THC.  The formulas have been developed to offer various health benefits, including an energy boost, hangover treatment, brain function boost, anxiety reduction, improved immunity, toxin removal and reduced inflammation.We have completed the taste profiling on the 8 fruit beverages and we are now in negotiations with several beverage manufacturers to complete stability testing and manufacture the drinks.  One of the key ingredients in all of these beverages is cannabis leaf extract, which we produce using our patent pending sonic and nano emulsion technology.  We are engaged in developing the brand and packaging for a hemp version and a cannabis version of our beverage line.FINANCIAL PERFORMANCEWe realized revenue of $800,714 for the three months ended February 28, 2019 as compared to $1,808,813 for the same period of the prior year. The decline in revenues was primarily due to a consulting contract in the prior year which generated revenue of $1,800,000 as a one-time revenue.  Licensing revenues are primarily driven by licensing contracts which do not have a pattern in timing.  We expect to continue to generate licensing revenues for years to come but the timing of the licensing revenue is mainly determined by the timing of such contracts. We launched our first product sales in this Quarter, with our lip balm launching in December, 2018, our anti-aging serum in January 2019 and our 3 moisturizers launching near the end of the of the quarter in February 2019.  The revenues for our products sales increased by 85% from the first month in the quarter to the third month. Since our financial quarter ended February 28, 2019, we have launched 6 more Urban Juve products, bringing the total number of SKUs for sale to 11.We anticipate launching 9 new products through the Wright and Well brand in Q2 and Q3, and with our aggressive marketing and sales efforts we expect our product revenues to increase substantially in Q2 and Q3.We incurred a net loss of $3,789,780 for the three months ended February 28, 2019 as compared to $638,347 for the same period of the prior year. The increase in loss was primarily driven by a decrease in licensing revenues and increased expenses.  We incurred significant marketing expenses, which included marketing and packaging design for our  brands with over 200 products in development, new websites in development for Urban Juve and Yield Growth launching in Q2, point of sales materials for our products, sales and educational materials to sign up retailers and support them in retail sales, preparation and attendance at cannabis focused events such as LIFT, social media, programmatic advertising, influencer programs, publicists, investor events, investor relations and digital marketing. We went public on stock exchanges in 3 countries in Q1 – including the CSE in Canada in December, the OTCQB in the United States in January and The Frankfurt Stock exchange in Germany in February, requiring significant investment into market awareness to launch into those marketsCAPITAL RESOURCES

Original story can be found at: http://www.globenewswire.com/news-release/2019/04/26/1810881/0/en/Yield-Growth-Reports-Revenue-of-800-714-in-First-Quarter-Financial-Results-and-Provides-Operational-Update.html?f=22&fvtc=5&fvtv=41223728

Cannabis News

[Winner] November 1, 2018 Giveaway (Episode 2)

William Mottl

Published

on

Brady Shepherd wins our 2nd Rate.Review.Win! Giveaway!

hosted by Automatic Weapons

Continue Reading

Cannabis News

Automatic Weapons to host November CannaMaps Giveaway!

William Mottl

Published

on

Automatic Weapons | CannaMaps

Rate.Review.Win! Giveaway Meme for November 1, 2018 hosted by Automatic Weapons.

Rate and Review ANY Listing on CannaMaps for a chance to Win $200 Diamond CBD Gift Card. CannaMaps shirt and some stickers!

Look out for other cool prizes coming soon from Hydrofarm via INDOOR GARDENS

Automatic Weapons is a band from Cleveland, Ohio as our guest HOST for this months LIVE SHOW at 4:20pm on November 1, 2018

https://DiamondCBD.com

Giveaway

 

CannaMaps-Automatic-Weapons-Ad

Continue Reading

Cannabis News

Cannabis could disrupt a $500 billion market, says CEO of top marijuana maker after deal with DEA

CannaNews

Published

on

Cannabis could disrupt a $500 billion market, says CEO of top marijuana maker after deal with DEA

It’s no secret that the world is growing accustomed to the business of cannabis, but for $9.6 billion Canadian medical marijuana producer Canopy Growth, the future is approaching faster than many expect.

On Tuesday, Canopy — which has gained traction on news of several-billion-dollar investments from Corona parent Constellation Brands — announced that it had shipped cannabis to the United States from Canada for medical research, a milestone in the U.S. government’s acceptance of what it considers to be a Schedule 1 drug.

“Under [Drug Enforcement Administration] approval, we shipped, for the first time, legally — and I highlight ‘legally’ — cannabis from Canada to the U.S,” Bruce Linton, the co-founder, Chairman and CEO of Canopy Growth, told CNBC’s Jim Cramer.

“The DEA-approved partner, which we haven’t announced yet, can actually begin to do medical research, clinical trials if necessary, [and] create the data set that enables people to know when, what, where, and maybe it can become federally regulated in the U.S. with some input that way,” Linton said in an interview on “Mad Money.”

Canopy’s news comes less than one month after competing Canadian marijuana producer Tilray announced DEA approval to import cannabis to the United States for medical research at the University of California San Diego Center for Medicinal Cannabis Research.

California is one of eight states, excluding the District of Columbia, to fully legalize medical and recreational marijuana use. Thirty U.S. states currently have laws legalizing medical marijuana use in some form.

Today, the world has its eyes on Canada, where full legalization of adult marijuana use is set to take effect on Oct. 17. While the windfall will likely be massive for producers like Canopy, Linton is focused on the longer-term global opportunity.

The CEO said Thursday that cannabis could disrupt some $500 billion worth of global markets, calling that a more “accurate” estimate than “conservative, cautious” predictions of a $200 billion disruption.

“We disrupt alcohol potentially, cigarettes potentially, in terms of smoking cessation,” he told Cramer. “We really disrupt pharmaceutical, because whether or not you’re geriatric care, you’re dealing with arthritic conditions, you’re someone who can’t sleep, you’re going through an oncology treatment, I think you’re going to find cannabinoid therapies really hit there.”

“And so you add all that together, plus the existing $200 billion illicit market, that pretty quickly gets you up around $500 billion,” Linton continued. “It sounds like a ‘How could it be?’ but just do a bit of the back-of-the-envelope math. It’s not crazy.”

Canada’s legalization could be Canopy’s key to seizing on that opportunity more than it already has, Linton added.

“Last week I was in the EU, the U.K. They know about Oct. 17 intimately and they’re trying to figure out, ‘Hm, if we’re a government or businesses, how do we quit ignoring cannabis and govern it, regulate it, tax it and turn it into something that might be medicinal and for sure a much better formatted product for a party?'” he said.

“And so what’s going to be the big bump isn’t just Canada,” he said. “If we do it right, Canopy leads. That gives us the position globally that then, all of a sudden, you add a zero or two to the number of people we’re trying to serve.”

U.S. shares of Canopy, the first cannabis company to be listed on the New York Stock Exchange, gained 5.64 percent Friday trading as the rest of the stock market recovered from its multi-day losing streak.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagramVine

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Article originally found at https://www.cnbc.com/2018/10/12/canopy-growth-ceo-cannabis-could-disrupt-a-500-billion-market.html

Continue Reading

Trending